"Polyethylene Glycols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS.
| Descriptor ID |
D011092
|
| MeSH Number(s) |
D02.033.455.250.700 D05.750.741 D25.720.741 J01.637.051.720.741
|
| Concept/Terms |
Polyethylene Glycols- Polyethylene Glycols
- Macrogols
- Macrogol
- Polyethylene Glycol
- Glycol, Polyethylene
- Glycols, Polyethylene
- Polyethylene Oxide
- Oxide, Polyethylene
- Oxides, Polyethylene
- Polyethylene Oxides
- Polyethyleneoxide
- Polyethyleneoxides
- Polyoxyethylenes
- Polyoxyethylene
- Tritons
|
Below are MeSH descriptors whose meaning is more general than "Polyethylene Glycols".
Below are MeSH descriptors whose meaning is more specific than "Polyethylene Glycols".
This graph shows the total number of publications written about "Polyethylene Glycols" by people in this website by year, and whether "Polyethylene Glycols" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 1 | 3 |
| 1997 | 2 | 1 | 3 |
| 1998 | 8 | 1 | 9 |
| 1999 | 0 | 3 | 3 |
| 2000 | 2 | 2 | 4 |
| 2001 | 6 | 1 | 7 |
| 2002 | 3 | 1 | 4 |
| 2003 | 4 | 4 | 8 |
| 2004 | 5 | 4 | 9 |
| 2005 | 8 | 4 | 12 |
| 2006 | 4 | 3 | 7 |
| 2007 | 7 | 7 | 14 |
| 2008 | 8 | 5 | 13 |
| 2009 | 3 | 7 | 10 |
| 2010 | 18 | 9 | 27 |
| 2011 | 14 | 6 | 20 |
| 2012 | 8 | 6 | 14 |
| 2013 | 8 | 3 | 11 |
| 2014 | 8 | 5 | 13 |
| 2015 | 1 | 7 | 8 |
| 2016 | 1 | 3 | 4 |
| 2017 | 4 | 7 | 11 |
| 2018 | 6 | 1 | 7 |
| 2019 | 2 | 5 | 7 |
| 2020 | 4 | 5 | 9 |
| 2021 | 3 | 4 | 7 |
| 2022 | 0 | 1 | 1 |
| 2023 | 1 | 1 | 2 |
| 2024 | 4 | 2 | 6 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Polyethylene Glycols" by people in Profiles.
-
One- and Two-Year Outcomes of Genicular Artery Embolization for Symptomatic Knee Osteoarthritis: A Single-Center, Retrospective Study Using 200-µm Polyethylene Glycol Microspheres. Cardiovasc Intervent Radiol. 2025 Dec; 48(12):1705-1713.
-
Measurement of Covalent Bond Formation in Light-Curing Hydrogels Predicts Physical Stability under Flow. Anal Chem. 2024 Dec 17; 96(50):19880-19888.
-
Patient-Specific Nanoparticle Targeting in Human Leukemia Blood. ACS Nano. 2024 10 22; 18(42):29021-29035.
-
Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans. ACS Nano. 2024 10 01; 18(39):27077-27089.
-
Replacing poly(ethylene glycol) with RAFT lipopolymers in mRNA lipid nanoparticle systems for effective gene delivery. Int J Pharm. 2024 Nov 15; 665:124695.
-
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma: The ATOMIC-Meso Randomized Clinical Trial. JAMA Oncol. 2024 04 01; 10(4):475-483.
-
Highly flexible PEG-LifeAct constructs act as tunable biomimetic actin crosslinkers. Soft Matter. 2024 Jan 31; 20(5):971-977.
-
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial. Lancet. 2023 Oct 21; 402(10411):1449-1458.
-
The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study. Blood Adv. 2023 01 24; 7(2):196-204.
-
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine. ACS Nano. 2022 08 23; 16(8):11769-11780.